Merck KGaA exec to become Millipore CEO

Merck KGaA executive Bernd Reckmann has been tapped as the new CEO of Millipore, which the German company bought back in March. Current Millipore CEO Martin Madaus will work as a consultant for the company after the $6 billion acquisition is complete. Report

Suggested Articles

Paragon Biosciences has hired Kerensa Jimenez as the new CEO of its capital markets group Paragon Health Capital.

Regeneron has taken a step closer to getting a green light for its experimental high cholesterol drug as the FDA allows a swift review of evicanumab.

An analysis of Gilead’s remdesivir clinical trials found the studies “failed to provide equal representation of Black, Latinx and Native Americas."